We are live on ! Find out more
TCMP

Thrive Capital Management (Pennsylvania) Portfolio holdings

AUM $530M
1-Year Est. Return 22.41%
This Fund
S&P 500
This Quarter Est. Return
+6.56%
1 Year Est. Return
+22.41%
3 Year Est. Return
+58.21%
5 Year Est. Return
+53.58%
10 Year Est. Return
AUM
$154M
AUM Growth
+$18.1M
Cap. Flow
+$9.94M
Cap. Flow %
6.47%
Top 10 Hldgs %
50.18%
Holding
128
New
21
Increased
27
Reduced
50
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 4.51%
2 Healthcare 3.28%
3 Consumer Staples 1.92%
4 Utilities 1.58%
5 Financials 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWOB icon
126
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
-3,116
Closed -$244K
VYM icon
127
Vanguard High Dividend Yield ETF
VYM
$83.5B
-2,330
Closed -$241K
TWTR
128
DELISTED
Twitter, Inc.
TWTR
-7,735
Closed -$467K

Similar funds

Thrive Capital Management (Pennsylvania)'s Q4 2021 Portfolio in Review

As of Q4 2021, Thrive Capital Management (Pennsylvania) held 128 positions worth $154M, up 13% from $135M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Thrive Capital Management (Pennsylvania) deployed $9.94M of net new capital in Q4 2021, opening 21 new positions and adding to 27 existing holdings. Its largest new stake was VanEck Semiconductor ETF: 12,506 shares worth $1.93M.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $1.82M trimmed.

  • Thrive Capital Management (Pennsylvania)'s largest Q4 2021 buy was VanEck Semiconductor ETF: 12,506 shares worth $1.93M.
  • Thrive Capital Management (Pennsylvania) added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q4 2021, an estimated $4.58M increase.
  • Thrive Capital Management (Pennsylvania)'s biggest Q4 2021 reduction was iShares Short Maturity Bond ETF, cutting an estimated $1.82M.
  • Thrive Capital Management (Pennsylvania) fully exited First Trust NYSE Arca Biotechnology Index Fund in Q4 2021, selling an estimated $713K.
  • Thrive Capital Management (Pennsylvania)'s ten largest holdings make up 50% of its $154M portfolio in Q4 2021.
  • Thrive Capital Management (Pennsylvania) opened 21 new positions and closed 27 in Q4 2021.
  • Thrive Capital Management (Pennsylvania)'s portfolio value rose 13% quarter-over-quarter to $154M.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q4 2021, filed 9 Feb 2022.